Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 3 of 1012345...10...Last »

Lonza to Host Mycoplasma Webinar

Cologne (Germany) / Walkersville, MD (USA), 23 February 2016 – Lonza has announced that it will host a free 60-minute webinar on 8 March 2016 titled “Mycoplasma – Uncover the Hidden Enemy in Cell Culture.” Mycoplasma contamination poses a considerable threat to cells in culture – and to the researcher it brings the potential loss […]

Read More »

HBA Metro presents: LinkedIn: What’s New? What’s Hot?

This webinar will help you understand what LinkedIn can and cannot do for you. You will learn about recent LinkedIn developments and how they can benefit your profile, and how to keep track of LinkedIn as it continues to evolve.

Read More »

J&J must pay $72 million for cancer death linked to talcum powder: lawyers

Johnson & Johnson (JNJ.N) was ordered by a Missouri state jury to pay $72 million of damages to the family of a woman whose death from ovarian cancer was linked to her use of the company’s talc-based Baby Powder and Shower to Shower for several decades. In a verdict announced late Monday night, jurors in […]

Read More »

FDA says PTC’s marketing application insufficient, shares slip

PTC Therapeutics Inc’s marketing application for its muscle disorder drug was not sufficient to merit a review, the U.S. Food and Drug Administration said, pushing the company’s stock down about 40 percent before the bell. PTC’s drug, translarna, is being evaluated in patients with Duchenne muscular dystrophy (DMD), a progressive degenerative disorder that hampers muscle […]

Read More »

Pronutria Biosciences Announces $42.5 Million Equity Investment from Nestlé Health Science

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Pronutria Biosciences Inc., a biotechnology company pioneering first-in-class medicines for serious conditions linked to amino acid imbalances, announced today that it has completed a $42.5 million investment by Nestlé Health Science. The proceeds from this financing will help to fund the ongoing rapid transformation of the company from a unique and revolutionary platform […]

Read More »

Authorities Raid Novartis AG Offices in Korea Over Bribery Allegations

Officials representing the Seoul Western District Prosecutors’ Office in South Korea raided the local offices of Switzerland-based Novartis AG (NVS), looking for evidence of bribery allegations.   According to the Yonhap News Agency, the Korean officials seized documents and account books on Monday around 9 a.m. local time. A Korean prosecution official said the raid […]

Read More »

IMS Health Increased Headcount by 4,800 in 2015

IMS Health Holdings reported an employee base numbering more than 15,000 people at the close of 2015, up from 10,200 a year earlier as the company absorbed business units of Cegedim it acquired for $426 million last April, as well as 14 smaller companies. Danbury-based IMS Health (NYSE: IMS) tracks pharmaceutical pricing and sales and […]

Read More »

Proof Eating Chocolate Makes Your Brain Work Better, University of South Australia Study

The Cognitive Benefits Of Eating Chocolate With Easter about a month away, it’s good news for chocolate lovers as new research has revealed that those who eat chocolate at least once per week performed better on multiple cognitive tasks, compared to those who ate chocolate less frequently. This research was undertaken by Dr Georgie Crichton, […]

Read More »

Bill Gates says Zika response better than for Ebola

The Bill and Melinda Gates Foundation has turned its attention to the Zika virus outbreak, and its founders said the response to the crisis, which may be linked to devastating birth defects in South America, has been better than for the 2014 Ebola outbreak in Africa. “We got deeply involved in Ebola, and we’re already […]

Read More »

FDA Accepts Sanofi New Drug Application for Once-Daily Fixed-Ratio Combination of Insulin Glargine and Lixisenatide

PARIS, Feb. 22, 2016 /PRNewswire/ — Sanofi announced today that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for its investigational fixed-ratio combination of basal insulin glargine 100 Units/mL and GLP-1 receptor agonist lixisenatide for the treatment of adults with type 2 diabetes. Following the redemption of a Priority Review […]

Read More »

EU approves Bayer’s Kovaltry for hemophilia A

The European Commission has approved Bayer’s haemophilia A drug Kovaltry for the treatment of patients from all age groups, the company said on Monday.   Kovaltry will complement Bayer’s existing haemophilia business, with Kogenate being the most important product. Haemophilia affects about 400,000 people around the world and is a mainly inherited disorder in which […]

Read More »

Amgen, UCB say osteoporosis drug meets main goal in late-stage trial

Amgen Inc and Belgium-based UCB SA said on Monday that their osteoporosis drug met all the primary endpoints by reducing the incidence of new vertebral fracture in postmenopausal women with osteoporosis in a late-stage study. The results, from a Fracture study in postmenopausal women with osteoporosis (FRAME), showed that the drug Romosozumab met a secondary […]

Read More »

China suspends Ali Health-run online drug monitoring platform

China’s food and drugs regulatory body said it had suspended its electronic drug monitoring system, a platform operated by Alibaba Health Information Technology Ltd, while it drafts amendments to regulations monitoring pharmaceutical sales. The China Food and Drug Administration (CFDA) said it will seek comments until March 23 on changes to the way pharmaceutical products […]

Read More »

South Africa confirms first case of Zika virus

South Africa confirmed its first case of the mosquito-borne Zika virus in a Columbian man, health authorities said.   The virus, which is causing international alarm after spreading through much of the Americas, was detected in the man on his visit to Johannesburg, Health Minister Aaron Motsoaledi said. “The businessman presented with fever and a […]

Read More »

U.S. proposes hike in Medicare Advantage payments; insurer shares rise

The U.S. government on Friday proposed raising payments by 1.35 percent on average next year to the health insurers who offer Medicare Advantage health benefits to elderly and disabled Americans. Payments to insurers will vary under the 2017 Medicare Advantage proposal, based on the region the plans are sold and on the size of bonus […]

Read More »

White House, House Republicans spar over Zika, Ebola funding

The White House said on Friday that it would be “profoundly unwise” to plow money set aside for Ebola-related projects into research and mitigation efforts for the mosquito-borne Zika virus as several top Republican lawmakers have requested. Democratic President Barack Obama has asked the U.S. Congress for more than $1.8 billion to fight Zika in […]

Read More »

Cambridge Biotech AVROBIO Launches with Former MassBio Chair as CEO

February 19, 2016By Mark Terry, Breaking News Staff   Cambridge, Mass.-based venture capital firm Atlas Venture launched another Cambridge biotech startup yesterday, AvroBio. No financial details were disclosed. The company is founded on two novel cell and gene therapies that came out of the laboratories of Christopher Paige and Jeffrey Medin at the University […]

Read More »

FDA approves UCB’s drug to treat epilepsy-related seizures

The U.S. Food and Drug Administration (FDA) approved Belgian drugmaker UCB SA’s drug as an add-on therapy to treat partial seizures caused by epilepsy. The FDA approval comes nearly two months after the European health regulators recommended approval of the drug, Briviact, in Europe. Briviact has been approved for use in epileptic patients who are […]

Read More »

Italy sees fewest births ever in 2015, population drops

Fewer babies were born in Italy in 2015 than in any year since the modern state was founded 154 years ago, and the population shrank for the first time in three decades, data showed on Friday. Adding to the gloomy picture, the number of deaths jumped more than 9 percent over the previous year. That […]

Read More »

Hemispherx Fires CEO Following Reexamination of Priorities

February 19, 2016By Alex Keown, Breaking News Staff   NEW BRUNSWICK, N.J. – Hemispherx Biopharma stock jumped about 13 cents per share, a five percent increase, following the termination of William Carter, the company’s chairman and chief executive officer, reported this morning. The company announced Carter’s Feb. 17 termination in a filing with […]

Read More »

Page 3 of 1012345...10...Last »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

February 2018 Focus: Top 10 Pipelines, Focused Value in Pharma, Agenda 2018 and MAHF!


Ad Right Bottom

Main Navigation